Abstract Body

There is little data on metabolic changes associated with boosted-lopinavir (r/LPV) containing second-line antiretroviral therapy (ART) after virological failure of first-line NNRTI+2N(t)RTI. We hypothesized that second-line ART containing thymidine analogue (ta)-NRTI+3[F]TC would confer a less favorable metabolic profile compared to TDF+3[F]TC.

SECOND-LINE was an open-label RCT conducted in 15 high- and middle-income countries. 541 participants received ritonavir-boosted lopinavir (LPV/r) with 2-3N(t)RTIs or raltegravir (RAL). N(t)RTIs were chosen by site investigators. 210 patients had DXA-scan soft tissue measurement at weeks 0 and 96. Participants were categorized into groups according to 2nd-line ART (ta-NRTI+3[F]TC+r/LPV; TDF+3[F]TC+r/LPV; TDF+ta-NRTI+/-3[F]TC+r/LPV; RAL+r/LPV), and pre-switch ART (TDF+3[F]TC+NNRTI or ta-NRTI+3[F]TC+NNRTI). For the TDF+ta-NRTI+/-3[F]TC+r/LPV group we combined participants who did (n=40/63) and did not (n=23/63) receive 3[F]TC. We analyzed the associations between (i) on-study second-line ART group and (ii) first-to-second-line ART switch and changes in fasted metabolic parameters [total cholesterol (TC), LDL-cholesterol (LDL-c), HDL-c, TC/HDL-c ratio, triglycerides (TG) and blood sugar (BSL), all reported in mmol/L] from baseline to week 96 after adjusting for confounders. We explored the association between metabolic and soft tissue changes in the DXA-scan subset. Linear regression methods were used. 

454 participants were analyzed. (i) on-study analysis: those on RAL+r/LPV had greater increase in TC (adjusted mean change (aMC)=0.65, 95%CI 0.33, 0.96), LDL-c (aMC=0.38, 95%CI 0.15, 0.61) and HDL-c (aMC=0.076, 95%CI -0.0013, 0.16) compared to TDF+3[F]TC+r/LPV. Participants who received ta-NRTI+3[F]TC+r/LPV experienced greater HDL-c increase compared to those on TDF+3[F]TC+r/LPV (aMC=0.22, 95% CI 0.05, 0.39). Those on RAL+r/LPV had a BSL increase when compared to both taNRTI+3[F]TC+r/LPV (aMC=0.89, 95%CI 0.09, 1.70) and TDF+3[F]TC+r/LPV (aMC=0.47, 95%CI -0.01, 0.92). Analysis (ii) metabolic changes by switch arm are displayed in Figure 1. Our exploratory analysis showed that a 1kg increase in trunk fat mass was independently associated with an increase in TC (ß=0.098 mmol/L, 95%CI 0.025-0.17) and LDL-c (ß=0.081 mmol/L, 95%CI 0.032-0.14).




These results describe the expected metabolic changes in patients switching from 1st- to 2nd-line N(t)RTI-containing or -sparing ART according to new WHO recommendations.